AU678201B2 - Improved amino acid solutions for treatment of peritoneal dialysis patients - Google Patents

Improved amino acid solutions for treatment of peritoneal dialysis patients

Info

Publication number
AU678201B2
AU678201B2 AU57488/94A AU5748894A AU678201B2 AU 678201 B2 AU678201 B2 AU 678201B2 AU 57488/94 A AU57488/94 A AU 57488/94A AU 5748894 A AU5748894 A AU 5748894A AU 678201 B2 AU678201 B2 AU 678201B2
Authority
AU
Australia
Prior art keywords
solution
meq
amino acid
amino acids
dialysis solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57488/94A
Other languages
English (en)
Other versions
AU5748894A (en
Inventor
Michael R Jones
Leo Martis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of AU5748894A publication Critical patent/AU5748894A/en
Application granted granted Critical
Publication of AU678201B2 publication Critical patent/AU678201B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
AU57488/94A 1992-12-22 1993-12-10 Improved amino acid solutions for treatment of peritoneal dialysis patients Ceased AU678201B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99585592A 1992-12-22 1992-12-22
US995855 1992-12-22
PCT/US1993/012077 WO1994014430A1 (en) 1992-12-22 1993-12-10 Improved amino acid solutions for treatment of peritoneal dialysis patients

Publications (2)

Publication Number Publication Date
AU5748894A AU5748894A (en) 1994-07-19
AU678201B2 true AU678201B2 (en) 1997-05-22

Family

ID=25542284

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57488/94A Ceased AU678201B2 (en) 1992-12-22 1993-12-10 Improved amino acid solutions for treatment of peritoneal dialysis patients

Country Status (14)

Country Link
US (3) US5670176A (da)
EP (1) EP0626845B1 (da)
JP (1) JP3483885B2 (da)
KR (1) KR100309972B1 (da)
AT (1) ATE226433T1 (da)
AU (1) AU678201B2 (da)
CA (1) CA2129998C (da)
DE (1) DE69332433T2 (da)
DK (1) DK0626845T3 (da)
ES (1) ES2185646T3 (da)
MX (1) MX9308002A (da)
NZ (1) NZ259242A (da)
SG (1) SG48704A1 (da)
WO (1) WO1994014430A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723690B1 (fr) * 1994-08-17 1996-09-27 Seb Sa Appareil de chauffe pour aliments, en particulier pour la realisation de fritures, comportant une contre-cuve
JPH1171273A (ja) * 1997-08-29 1999-03-16 Terumo Corp 腹膜透析液
AU751556B2 (en) * 1998-01-05 2002-08-22 Johns Hopkins University, The Supplement for dialysis patients
DE69927093T2 (de) * 1998-07-07 2006-06-29 Terumo K.K. Lösung für die Peritonealdialyse
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
ATE405277T1 (de) 1999-04-26 2008-09-15 Edwards Lifesciences Ag Substitutions-infusionflüssigkeit und zitratanticoagulation
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US6830692B1 (en) * 1999-09-20 2004-12-14 Degussa Ag Amino acid composition for hemodialysis
US6787039B2 (en) * 2001-01-26 2004-09-07 Degussa Ag Amino acid composition for hemodialysis
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
CN100417380C (zh) * 2005-12-14 2008-09-10 于力犁 透析液用氨基酸粉/液、其复合透析液粉/液及制备方法
WO2009120968A2 (en) * 2008-03-27 2009-10-01 Affinergy Inc. Coating compositions having improved performance
CN102370640A (zh) * 2010-08-18 2012-03-14 俞黎黎 血液透析用复方氨基酸制剂及含复方氨基酸的血液透析用制剂
EP2489408A1 (de) 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
CN105640946A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 氨基酸（15）乳酸盐腹膜透析液药物组合物
CN105640947A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 碱性必需氨基酸乳酸盐腹膜透析液药物组合物
CN105560275A (zh) * 2014-11-10 2016-05-11 天津金耀集团有限公司 碱性低钙必需氨基酸腹膜透析液药物组合物
CN105640948A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 必需氨基酸乳酸盐腹膜透析液药物组合物
CN105640945A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 低钙必需氨基酸腹膜透析液药物组合物
LT3226854T (lt) * 2014-12-04 2020-04-27 Professional Dietetics International S.r.l. in forma abbreviata P.D. INT. S.R.L. Aminorūgštimi paremta kompozicija skirta fibroelastino atkūrimui odos jungiamuosiuose audiniuose
CA3033333C (en) 2015-09-21 2024-06-18 The Board Of Trustees Of The Leland Stanford Junior University Nutritional treatment for cancer
US10342824B2 (en) 2017-07-17 2019-07-09 Dr. Marlowe's Weight Loss Institute, P.L.L.C. Supplement for treating side effects of medications which cause metabolic acidosis
CA3084319A1 (en) * 2017-12-11 2019-06-20 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58500563A (ja) * 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
DE3821043A1 (de) * 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung
DE3843289A1 (de) * 1988-12-22 1990-06-28 Diehl Gmbh & Co Treibspiegelmunition
ATE169223T1 (de) * 1992-02-04 1998-08-15 Baxter Int Peritonealdialyselösungen die mindestens ein dipeptid enthalten
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution

Also Published As

Publication number Publication date
CA2129998C (en) 2006-07-11
ATE226433T1 (de) 2002-11-15
ES2185646T3 (es) 2003-05-01
KR100309972B1 (ko) 2001-12-28
JPH07504210A (ja) 1995-05-11
DK0626845T3 (da) 2003-02-17
US5776503A (en) 1998-07-07
CA2129998A1 (en) 1994-07-07
JP3483885B2 (ja) 2004-01-06
DE69332433D1 (de) 2002-11-28
US5670176A (en) 1997-09-23
KR950700059A (ko) 1995-01-16
AU5748894A (en) 1994-07-19
NZ259242A (en) 1997-03-24
EP0626845A1 (en) 1994-12-07
US5698230A (en) 1997-12-16
WO1994014430A1 (en) 1994-07-07
DE69332433T2 (de) 2003-08-14
EP0626845B1 (en) 2002-10-23
SG48704A1 (en) 1998-05-18
MX9308002A (es) 1994-08-31

Similar Documents

Publication Publication Date Title
AU678201B2 (en) Improved amino acid solutions for treatment of peritoneal dialysis patients
Bruno et al. CAPD with an amino acid dialysis solution: a long-term, cross-over study
Bergström Nutrition and mortality in hemodialysis.
US6306836B1 (en) Peritoneal dialysis solutions containing maltodextrins and amino acids
Mortelmans et al. Intradialytic parenteral nutrition in malnourished hemodialysis patients: a prospective long‐term study
EP0078832B1 (en) Dialysis solution containing glycerol
AU2655195A (en) Biochemically balanced peritoneal dialysis solutions
US7932291B2 (en) Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
Blackburn et al. Criteria for choosing amino acid therapy in acute renal failure
US6730660B2 (en) Peritoneal dialysis solutions with polypeptides
Giordano et al. Effects of catabolic stress in acute and chronic renal failure
JPH0670718A (ja) 栄養組成物
Bachmann Treatment of congenital hyperammonemias
JPH06509362A (ja) アルファ−ケトルグルタル酸塩の用法
Ledebo Acid–base correction and convective dialysis therapies
Digenis et al. Malnutrition in continuous ambulatory peritoneal dialysis and use of intraperitoneal amino acids
CA1239586A (en) Dialysis solution containing amino acids
Fogel et al. Carbon tetrachloride poisoning treated with hemodialysis and total parenteral nutrition.
de Baulny et al. Emergency treatments
Giordano et al. Peritoneal Nutrition in Children—Preliminary Results in Renal Failure
Pedersen Alternate use of amino acid and glucose solutions in CAPD
Hecking et al. Supplementation with essential amino acids or α-keto analogues in patients on long-term hemodialysis
Goodship et al. Amino Acid Dialysate1